Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Quantum Dot Corporation Launches Mosaic™

Abstract:
New tool for pharmaceutical, biotechnology and functional genomics researchers

Quantum Dot Corporation Launches the Mosaic™ Gene Expression Assay System: a Unique Combination of Quality Controls, Performance and Throughput for Multiplexed mRNA Quantification

Hayward, CA | March 21, 2005

Quantum Dot Corporation announces launch of the Mosaic Gene Expression Assay System. For the first time, pharmaceutical, biotechnology and functional genomics researchers can measure quantitative expression of 100 user-specified mRNAs simultaneously from small amounts of input sample. The Mosaic System offers a unique combination of features, including:

  • Custom multiplex of 100 user-specified genes; 200 genes will be available later in 2005
  • Calibrators and assay quality controls built into every assay
  • Exceptional technical performance
           o Sensitivity comparable to qPCR with better precision
           o Measure less than 1.4-fold changes in mRNA expression
  • High throughput for large projects: 360 samples of 100 genes per sample in 24 hours

“The combination of quality controls in every assay, exceptional performance, throughput and project cost savings brings tremendous benefit to researchers and a better way to implement gene expression analysis for discovery, compound screening and lead validation,” cites Senior Marketing Manager, Stephen Chamberlain, Ph.D.

The Mosaic System includes the Mosaic Q1000 Scanner and computer, Mosaic software, and custom Gene Panels configured in convenient kit format; the assay is designed for automated processing on liquid-handling workstations. Each custom Gene Panel is designed and manufactured with gene-specific beads that are spectrally coded with the QDC’s innovative Qdot® nanocrystals. Fluorescent spectral codes are identified and gene data is measured by the Mosaic Q1000 Scanner and analyzed by the Mosaic Data Collector and Expression Manager Software modules.

Quantum Dot CEO, George Dunbar explains, “This cutting edge technology, combined with QDC’s Qdot nanocrystal expertise, not only allows scientists to perform fine gene expression research on the most important subsets of genes for compound discovery and development, but also satisfies new demands in emerging fields such as Translational and Molecular Medicine.”

About Quantum Dot Corporation
Quantum Dot Corporation (QDC) is a privately held bioscience company that pioneered the development and commercialization of Qdot® nanocrystals for bio-detection in discovery and clinical applications. QDC’s current products include life-science kits and applications used by academic and pharmaceutical-discovery laboratories worldwide. In addition, QDC recently launched its first integrated instrumentation, software, and bio-reagents platform, the Mosaic™ System, for rapid and quantitative multiplexed gene expression analysis. QDC collaborates with leading academic and industrial partners and has over 150 patents and patentspending. For more information, visit www.qdots.com.



Contact:
George Dunbar
CEO, Quantum Dot Corporation
(510) 887 8775, ext. 4101

Gayle Kuokka
CFO, Quantum Dot Corporation
(510) 887 8775, ext. 4199

Copyright © Quantum Dot Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

In borophene, boundaries are no barrier: Rice U., Northwestern researchers make and test atom-thick boron's unique domains July 17th, 2018

Tuning into quantum: Scientists unlock signal frequency control of precision atom qubits July 16th, 2018

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Tools

Oxford Instruments’ 22 Tesla superconducting magnet system commissioned at the UAM, making it the most intense magnetic field available outside a large international facility July 12th, 2018

Nanometrics to Announce Second Quarter Financial Results on July 31, 2018 July 12th, 2018

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

The Institute of Applied Physics at the University of Tsukuba near Tokyo in Japan uses Deben's ARM2 detector to better understand catalytic reaction mechanisms June 27th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project